The Chinese University of Hong Kong

Immuno Cure and PharmaJet signed a collaboration agreement to evaluate the HIV therapeutic DNA vaccine ICVAX using PharmaJet's needle-free Tropis intradermal delivery system in clinical trials.

Cornerstone Robotics raised over $70 million in Series C funding led by EQT to accelerate commercialization of its Sentire endoscopic surgical system and challenge established players like da Vinci.

A multinational study led by Chinese University of Hong Kong researchers found that D3S-001, a mainland-developed cancer drug, effectively treats tumors driven by KRAS-G12C gene mutations.

CU Medicine research demonstrates that AI-assisted colonoscopy significantly improves adenoma detection rates by 40% among junior endoscopists with less than three years of experience.

A randomized, triple-blind, placebo-controlled clinical trial by Chinese University of Hong Kong demonstrated that SIM01, an oral microencapsulated live bacteria formula, significantly improved long COVID symptoms compared to placebo.

A multinational study led by Chinese University researchers found that D3S-001, a mainland-developed KRAS-G12C inhibitor, demonstrated significant efficacy with over 70% of patients experiencing tumor shrinkage or disappearance.